The Long-term Safety and Efficacy of SerpinPC in Subjects with Hemophilia Who Completed a Sponsored SerpinPC Clinical Trial

Clinical trial NCT06568302 · TERMINATED

Trial details

NCT number: NCT06568302
Sponsor: ApcinteX Ltd
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophilia a Hemophilia B Hemophilia a with Inhibitor Hemophilia B with Inhibitor

Start date: 2024-07-11
Primary completion: 2025-01-29
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.